Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing), By End Use (Clinics, Home), By Country, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Asia Pacific Construction Films Market Growth & Trends
The Asia Pacific construction films market size is estimated at USD 19.4 billion in 2030 and is expected to grow at a CAGR of 6.4% from 2024 to 2030. These films are increasingly being preferred in residential and commercial sector owing to their low maintenance and easy handling attributes.
Rapid urbanization, rising safety concerns and changing lifestyles backed by increasing disposable income in Asia Pacific economies have influenced consumption trends of materials. This has led to increased application scope in fittings and accessories for housing apartments.
Presence of enormous consumer base for housing and low-cost labor backed by broadening of plastic trade has created numerous opportunities for industry participants. The increasing application scope of puncture & scratch resistance films in green building practices has also led to their proliferation in environment control events.
These barriers are rapidly gaining popularity in tropical countries, with high precipitation level on account of outstanding moisture & humidity control properties.
Asia Pacific Construction Films Market Report Highlights
Asia Pacific Construction Films Market Growth & Trends
The Asia Pacific construction films market size is estimated at USD 19.4 billion in 2030 and is expected to grow at a CAGR of 6.4% from 2024 to 2030. These films are increasingly being preferred in residential and commercial sector owing to their low maintenance and easy handling attributes.
Rapid urbanization, rising safety concerns and changing lifestyles backed by increasing disposable income in Asia Pacific economies have influenced consumption trends of materials. This has led to increased application scope in fittings and accessories for housing apartments.
Presence of enormous consumer base for housing and low-cost labor backed by broadening of plastic trade has created numerous opportunities for industry participants. The increasing application scope of puncture & scratch resistance films in green building practices has also led to their proliferation in environment control events.
These barriers are rapidly gaining popularity in tropical countries, with high precipitation level on account of outstanding moisture & humidity control properties.
Asia Pacific Construction Films Market Report Highlights
- Advancements in manufacturing processes and technologies coupled with high quality plastic materials is expected to drive the product demand in coming years
- Refurbishment and restoration account for majority of the building activities in Japan due to the country’s susceptibility to natural disasters. These activities will yield a positive influence on industry growth in future
- Companies are involved in novel product development with improved repulsive characteristics, which are ideal for modern architectural applications
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Asia Pacific Point of Care Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Asia Pacific Point of Care Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030
4.2.1. Glucose Testing
4.2.1.1. Glucose Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.2. Hb1Ac Testing
4.2.2.1. Hb1Ac Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3. Coagulation Testing
4.2.3.1. Coagulation Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.4. Fertility/Pregnancy
4.2.4.1. Fertility/Pregnancy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5. Infectious Diseases
4.2.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.1. HIV POC
4.2.5.1.1.1. HIV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.2. Clostridium Difficile POC
4.2.5.1.2.1. Clostridium Difficile POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.3. HBV POC
4.2.5.1.3.1. HBV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.4. Pneumonia or Streptococcus Associated Infections
4.2.5.1.4.1. Pneumonia or Streptococcus Associated Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.5. Respiratory Syncytial Virus (RSV) POC
4.2.5.1.5.1. Respiratory Syncytial Virus (RSV) POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.6. HPV POC
4.2.5.1.6.1. HPV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.7. Influenza/Flu POC
4.2.5.1.7.1. Influenza/Flu POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.8. HCV POC
4.2.5.1.8.1. HCV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.9. MRSA POC
4.2.5.1.9.1. MRSA POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.10. TB And Drug-Resistant TB POC
4.2.5.1.10.1. TB And Drug-Resistant TB POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.11. HSV POC
4.2.5.1.11.1. HSV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.12. COVID-19
4.2.5.1.12.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.13. Other Infectious Diseases
4.2.5.1.13.1. Other Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.6. Cardiac Markers
4.2.6.1.1. Cardiac Makers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.7. Thyroid Stimulating Hormone
4.2.7.1.1. Thyroid Stimulating Market Hormone Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.8. Hematology
4.2.8.1.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.9. Primary Care Systems
4.2.9.1.1. Primary Care Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.10. Decentralized Clinical Chemistry
4.2.10.1.1. Decentralized Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.11. Feces
4.2.11.1.1. Feces Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.12. Lipid Testing
4.2.12.1.1. Lipid Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.13. Cancer Maker
4.2.13.1.1. Cancer Maker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.14. Blood Gas/Electrolytes
4.2.14.1.1. Blood Gas/Electrolytes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.15. Ambulatory Chemistry
4.2.15.1.1. Ambulatory Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.16. Drug of Abuse (DOA) Testing
4.2.16.1.1. Drug of Abuse (DOA) Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.17. Autoimmune Diseases
4.2.17.1.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.18. Urinalysis/Nephrology
4.2.18.1.1. Urinalysis/Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Asia Pacific Point of Care Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
5.2.1. Clinics
5.2.1.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.2. Pharmacy & Retail Clinics
5.2.1.2.1. Pharmacy & Retail Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.3. Physician Office
5.2.1.3.1. Physician Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.4. Urgent Care Clinics
5.2.1.4.1. Urgent Care Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.5. Non-practice Clinics
5.2.1.5.1. Non-practice Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. Hospitals
5.2.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Home
5.2.3.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Assisted Living Healthcare Facilities
5.2.4.1. Assisted Living Healthcare Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.5. Laboratory
5.2.5.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Outlook
6.1.1. Asia Pacific Point of Care Diagnostics Market By Region: Key Takeaways
7.2. China
6.1.2. China Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.3. Japan
6.1.3. Japan Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.4. India
6.1.4. India Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.5. South Korea
6.1.5. South Korea Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.6. Australia
6.1.6. Australia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.7. Thailand
6.1.7. Thailand Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.8. Malaysia
6.1.8. Malaysia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.9. Singapore
6.1.9. Singapore Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.10. Vietnam
6.1.10. Vietnam Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.11. Indonesia
6.1.11. Indonesia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. CHAPTER 7. COMPETITIVE LANDSCAPE
7.12. Recent Developments & Impact Analysis by Key Market Participants
7.13. Company Categorization
7.14. Company Heat Map Analysis
7.15. Company Profiles
7.15.1. F. Hoffman La-Roche Ltd
7.15.1.1. Participant’s Overview
7.15.1.2. Financial Performance
7.15.1.3. Product Benchmarking
7.15.1.4. Recent Developments/ Strategic Initiatives
7.15.2. Qiagen
7.15.2.1. Participant’s Overview
7.15.2.2. Financial Performance
7.15.2.3. Product Benchmarking
7.15.2.4. Recent Developments/ Strategic Initiatives
7.15.3. Danaher Corporation
7.15.3.1. Participant’s Overview
7.15.3.2. Financial Performance
7.15.3.3. Product Benchmarking
7.15.3.4. Recent Developments/ Strategic Initiatives
7.15.4. Becton and Dickinson (BD)
7.15.4.1. Participant’s Overview
7.15.4.2. Financial Performance
7.15.4.3. Product Benchmarking
7.15.4.4. Recent Developments/ Strategic Initiatives
7.15.5. bioMerieux
7.15.5.1. Participant’s Overview
7.15.5.2. Financial Performance
7.15.5.3. Product Benchmarking
7.15.5.4. Recent Developments/ Strategic Initiatives
7.15.6. Abbott
7.15.6.1. Participant’s Overview
7.15.6.2. Financial Performance
7.15.6.3. Product Benchmarking
7.15.6.4. Recent Developments/ Strategic Initiatives
7.15.7. Siemens Healthcare GmbH
7.15.7.1. Participant’s Overview
7.15.7.2. Financial Performance
7.15.7.3. Product Benchmarking
7.15.7.4. Recent Developments/ Strategic Initiatives
7.15.8. Werfen
7.15.8.1. Participant’s Overview
7.15.8.2. Financial Performance
7.15.8.3. Product Benchmarking
7.15.8.4. Recent Developments/ Strategic Initiatives
7.15.9. Nova Biomedical
7.15.9.1. Participant’s Overview
7.15.9.2. Financial Performance
7.15.9.3. Product Benchmarking
7.15.9.4. Recent Developments/ Strategic Initiatives
7.15.10. Trividia Health, Inc.
7.15.10.1. Participant’s Overview
7.15.10.2. Financial Performance
7.15.10.3. Product Benchmarking
7.15.10.4. Recent Developments/ Strategic Initiatives
7.15.11. SEKISUI MEDICAL Co. LTD
7.15.11.1. Participant’s Overview
7.15.11.2. Financial Performance
7.15.11.3. Product Benchmarking
7.15.11.4. Recent Developments/ Strategic Initiatives
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Asia Pacific Point of Care Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Economic and Social Landscape
3.4.2.3. Technological Landscape
3.4.2.4. Environmental Landscape
3.4.2.5. Legal Landscape
CHAPTER 4. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Asia Pacific Point of Care Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030
4.2.1. Glucose Testing
4.2.1.1. Glucose Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.2. Hb1Ac Testing
4.2.2.1. Hb1Ac Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.3. Coagulation Testing
4.2.3.1. Coagulation Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.4. Fertility/Pregnancy
4.2.4.1. Fertility/Pregnancy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5. Infectious Diseases
4.2.5.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.1. HIV POC
4.2.5.1.1.1. HIV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.2. Clostridium Difficile POC
4.2.5.1.2.1. Clostridium Difficile POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.3. HBV POC
4.2.5.1.3.1. HBV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.4. Pneumonia or Streptococcus Associated Infections
4.2.5.1.4.1. Pneumonia or Streptococcus Associated Infections Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.5. Respiratory Syncytial Virus (RSV) POC
4.2.5.1.5.1. Respiratory Syncytial Virus (RSV) POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.6. HPV POC
4.2.5.1.6.1. HPV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.7. Influenza/Flu POC
4.2.5.1.7.1. Influenza/Flu POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.8. HCV POC
4.2.5.1.8.1. HCV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.9. MRSA POC
4.2.5.1.9.1. MRSA POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.10. TB And Drug-Resistant TB POC
4.2.5.1.10.1. TB And Drug-Resistant TB POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.11. HSV POC
4.2.5.1.11.1. HSV POC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.12. COVID-19
4.2.5.1.12.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.5.1.13. Other Infectious Diseases
4.2.5.1.13.1. Other Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.6. Cardiac Markers
4.2.6.1.1. Cardiac Makers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.7. Thyroid Stimulating Hormone
4.2.7.1.1. Thyroid Stimulating Market Hormone Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.8. Hematology
4.2.8.1.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.9. Primary Care Systems
4.2.9.1.1. Primary Care Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.10. Decentralized Clinical Chemistry
4.2.10.1.1. Decentralized Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.11. Feces
4.2.11.1.1. Feces Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.12. Lipid Testing
4.2.12.1.1. Lipid Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.13. Cancer Maker
4.2.13.1.1. Cancer Maker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.14. Blood Gas/Electrolytes
4.2.14.1.1. Blood Gas/Electrolytes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.15. Ambulatory Chemistry
4.2.15.1.1. Ambulatory Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.16. Drug of Abuse (DOA) Testing
4.2.16.1.1. Drug of Abuse (DOA) Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.17. Autoimmune Diseases
4.2.17.1.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.2.18. Urinalysis/Nephrology
4.2.18.1.1. Urinalysis/Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Asia Pacific Point of Care Diagnostics Market: End Use Movement Analysis, USD Million, 2023 & 2030
5.2.1. Clinics
5.2.1.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.2. Pharmacy & Retail Clinics
5.2.1.2.1. Pharmacy & Retail Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.3. Physician Office
5.2.1.3.1. Physician Office Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.4. Urgent Care Clinics
5.2.1.4.1. Urgent Care Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.1.5. Non-practice Clinics
5.2.1.5.1. Non-practice Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. Hospitals
5.2.2.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Home
5.2.3.1. Home Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Assisted Living Healthcare Facilities
5.2.4.1. Assisted Living Healthcare Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.5. Laboratory
5.2.5.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. ASIA PACIFIC POINT OF CARE DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional Outlook
6.1.1. Asia Pacific Point of Care Diagnostics Market By Region: Key Takeaways
7.2. China
6.1.2. China Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.3. Japan
6.1.3. Japan Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.4. India
6.1.4. India Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.5. South Korea
6.1.5. South Korea Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.6. Australia
6.1.6. Australia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.7. Thailand
6.1.7. Thailand Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.8. Malaysia
6.1.8. Malaysia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.9. Singapore
6.1.9. Singapore Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.10. Vietnam
6.1.10. Vietnam Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
7.11. Indonesia
6.1.11. Indonesia Market Revenue Estimates and Forecast, 2018 - 2030 (USD Million)
CHAPTER 7. CHAPTER 7. COMPETITIVE LANDSCAPE
7.12. Recent Developments & Impact Analysis by Key Market Participants
7.13. Company Categorization
7.14. Company Heat Map Analysis
7.15. Company Profiles
7.15.1. F. Hoffman La-Roche Ltd
7.15.1.1. Participant’s Overview
7.15.1.2. Financial Performance
7.15.1.3. Product Benchmarking
7.15.1.4. Recent Developments/ Strategic Initiatives
7.15.2. Qiagen
7.15.2.1. Participant’s Overview
7.15.2.2. Financial Performance
7.15.2.3. Product Benchmarking
7.15.2.4. Recent Developments/ Strategic Initiatives
7.15.3. Danaher Corporation
7.15.3.1. Participant’s Overview
7.15.3.2. Financial Performance
7.15.3.3. Product Benchmarking
7.15.3.4. Recent Developments/ Strategic Initiatives
7.15.4. Becton and Dickinson (BD)
7.15.4.1. Participant’s Overview
7.15.4.2. Financial Performance
7.15.4.3. Product Benchmarking
7.15.4.4. Recent Developments/ Strategic Initiatives
7.15.5. bioMerieux
7.15.5.1. Participant’s Overview
7.15.5.2. Financial Performance
7.15.5.3. Product Benchmarking
7.15.5.4. Recent Developments/ Strategic Initiatives
7.15.6. Abbott
7.15.6.1. Participant’s Overview
7.15.6.2. Financial Performance
7.15.6.3. Product Benchmarking
7.15.6.4. Recent Developments/ Strategic Initiatives
7.15.7. Siemens Healthcare GmbH
7.15.7.1. Participant’s Overview
7.15.7.2. Financial Performance
7.15.7.3. Product Benchmarking
7.15.7.4. Recent Developments/ Strategic Initiatives
7.15.8. Werfen
7.15.8.1. Participant’s Overview
7.15.8.2. Financial Performance
7.15.8.3. Product Benchmarking
7.15.8.4. Recent Developments/ Strategic Initiatives
7.15.9. Nova Biomedical
7.15.9.1. Participant’s Overview
7.15.9.2. Financial Performance
7.15.9.3. Product Benchmarking
7.15.9.4. Recent Developments/ Strategic Initiatives
7.15.10. Trividia Health, Inc.
7.15.10.1. Participant’s Overview
7.15.10.2. Financial Performance
7.15.10.3. Product Benchmarking
7.15.10.4. Recent Developments/ Strategic Initiatives
7.15.11. SEKISUI MEDICAL Co. LTD
7.15.11.1. Participant’s Overview
7.15.11.2. Financial Performance
7.15.11.3. Product Benchmarking
7.15.11.4. Recent Developments/ Strategic Initiatives
